AU2986595A - Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma - Google Patents

Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma

Info

Publication number
AU2986595A
AU2986595A AU29865/95A AU2986595A AU2986595A AU 2986595 A AU2986595 A AU 2986595A AU 29865/95 A AU29865/95 A AU 29865/95A AU 2986595 A AU2986595 A AU 2986595A AU 2986595 A AU2986595 A AU 2986595A
Authority
AU
Australia
Prior art keywords
prophylactic
diagnosis
materials
therapeutic treatment
methods relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29865/95A
Inventor
Colin Stephen Cooper
Barry Austin Gusterson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Campaign Technology Ltd
Original Assignee
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Campaign Technology Ltd filed Critical Cancer Research Campaign Technology Ltd
Publication of AU2986595A publication Critical patent/AU2986595A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU29865/95A 1994-07-19 1995-07-19 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma Abandoned AU2986595A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9414580 1994-07-19
GB9414580A GB9414580D0 (en) 1994-07-19 1994-07-19 Materials and methods relating to the diagnosis of synovial sarcomas
PCT/GB1995/001704 WO1996002641A2 (en) 1994-07-19 1995-07-19 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma

Publications (1)

Publication Number Publication Date
AU2986595A true AU2986595A (en) 1996-02-16

Family

ID=10758576

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29865/95A Abandoned AU2986595A (en) 1994-07-19 1995-07-19 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma

Country Status (5)

Country Link
EP (1) EP0769053A2 (en)
AU (1) AU2986595A (en)
CA (1) CA2195531A1 (en)
GB (1) GB9414580D0 (en)
WO (1) WO1996002641A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291658B1 (en) 1997-05-05 2001-09-18 Ludwig Institute For Cancer Research Isolated nucleic acid molecules encoding SSX family members and thereof
US6287756B1 (en) * 1997-05-05 2001-09-11 Ludwig Institute For Cancer Research Methods for determining presence of cancer in a sample by determining expression of an SSX gene
US6548064B1 (en) * 1997-05-05 2003-04-15 Ludwig Institute For Cancer Research Isolated peptides consisting of amino acid sequences found in SSX or NY-ESO-1 molecules, which bind to HLA molecules
US6800730B1 (en) * 1998-10-02 2004-10-05 Ludwig Institute For Cancer Research Isolated peptides which bind to MHC class II molecules, and uses thereof
US7803370B2 (en) 2002-08-30 2010-09-28 Oncotherapy Science, Inc. Method for treating synovial sarcoma
WO2004020668A2 (en) * 2002-08-30 2004-03-11 Oncotherapy Science, Inc. Method for treating synovial sarcoma
ATE545658T1 (en) * 2003-07-11 2012-03-15 Oncotherapy Science Inc METHOD FOR TREATING SYNOVIAL SARCOMA
WO2005010190A1 (en) 2003-07-22 2005-02-03 Ludwig Institute For Cancer Research Ssx-2 peptides presented by hla class ii molucules
EP2044123B1 (en) 2006-06-21 2013-03-13 Oncotherapy Science, Inc. Tumor-targeting monoclonal antibodies to fzd10 and uses thereof
WO2009018018A2 (en) * 2007-07-31 2009-02-05 University Of Utah Research Foundation Animal model of synovial sarcoma
CN101970456B (en) * 2008-01-31 2014-11-26 国立大学法人大阪大学 Tag peptide and use thereof
TWI762516B (en) 2016-10-06 2022-05-01 日商腫瘤療法 科學股份有限公司 Monoclonal antibodies against FZD10 and their uses
CN110660451B (en) * 2018-06-13 2023-04-28 广州华大基因医学检验所有限公司 Method, device and application for determining whether fusion genes exist in biological sample

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084566A (en) * 1987-05-04 1992-01-28 Michael Litt DNA probe which reveals a hypervariable region on human chromosone 1

Also Published As

Publication number Publication date
EP0769053A2 (en) 1997-04-23
WO1996002641A3 (en) 1996-03-07
WO1996002641A2 (en) 1996-02-01
GB9414580D0 (en) 1994-09-07
CA2195531A1 (en) 1996-02-01

Similar Documents

Publication Publication Date Title
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
AU4658489A (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma
AU4130497A (en) Materials and methods relating to the diagnosis and treatment of diabetes and obesity
AU7772794A (en) Treatment of obesity
AU4536096A (en) Indole derivatives useful in the treatment of osteoporosis
AU2986595A (en) Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
EP0761718A3 (en) Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
PL321741A1 (en) Bicyclic derivatives of isothiourea useful in medical therapy
EP0761721A3 (en) Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
EP0761719A3 (en) Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
AU4604697A (en) Compositions and methods for the treatment of human cytomegalovirus infection
EP0761720A3 (en) Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
AU4096789A (en) The use of lactam derivatives in the treatment of cognitive disorders
IL117191A0 (en) Process for the preparation of oxazolidinones and their use
AU3456793A (en) Macrocyclic compounds in the prophylactic treatment of aids
AU3742295A (en) Purine and 8-azapurine derivatives suitable to the therapeutic treatment of aids
AU641157B2 (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma
AU1587295A (en) The treatment of gaseous substances
AU4020597A (en) Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of papillary renal cell carcinoma
GB9523959D0 (en) Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of cancer
GB9525555D0 (en) Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of cancer
GB9523984D0 (en) Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of tuberculosis
GB9617961D0 (en) Materials and methods relating to the diagnosis and prophylactic and therapeuti treatment of cancer